
In 101 Italian adults on stable RAS blockade, SGLT2 inhibitor add-on was tied to lower 12-month proteinuria but no eGFR slope change.

Domenico Santoro, MD, PhD is a full professor of nephrology and director of the Division of Nephrology and Dialysis at the University of Messina in Italy

In 101 Italian adults on stable RAS blockade, SGLT2 inhibitor add-on was tied to lower 12-month proteinuria but no eGFR slope change.